Search research articles
Contact Us
Filters
Showing results (101-110 of 393) with videos related to
Page
of 40
Sort By:
Hepatology Communications
|
September 30, 2022
Gaps in hepatocellular carcinoma surveillance among insured patients with hepatitis B infection without cirrhosis in the United States
Mindie H Nguyen, Lewis R Roberts, Nicole M Engel-Nitz, et al.
Cancers
|
November 13, 2021
<i>Sulfatase</i>-2 Regulates Liver Fibrosis through the TGF-β Signaling Pathway
Ikuo Nakamura, Faizal Z Asumda, Catherine D Moser, et al.
Hepatology (Baltimore, Md.)
|
January 24, 2018
Hepatic stellate cell-derived platelet-derived growth factor receptor-alpha-enriched extracellular vesicles promote liver fibrosis in mice through SHP2
Enis Kostallari, Petra Hirsova, Alena Prasnicka, et al.
Expert Opinion on Therapeutic Targets
|
January 17, 2022
Novel and emerging targets for cholangiocarcinoma progression: therapeutic implications
Lionel A Kankeu Fonkoua, Pedro Luiz Serrano Uson Junior, Kabir Mody, et al.
Hepatology (Baltimore, Md.)
|
April 9, 2013
Reply: To PMID 23055147
Roongruedee Chaiteerakij, William S Harmsen, Euijung Ryu, et al.
Scientific Reports
|
March 7, 2017
Inhibiting histone deacetylases suppresses glucose metabolism and hepatocellular carcinoma growth by restoring FBP1 expression
Jing Yang, Xin Jin, Yuqian Yan, et al.
Mayo Clinic Proceedings
|
August 8, 2015
Prognostic Value of Model for End-Stage Liver Disease Score Measurements on a Daily Basis in Critically Ill Patients With Cirrhosis
Thoetchai Peeraphatdit, Niyada Naksuk, Charat Thongprayoon, et al.
Breast Cancer Research : BCR
|
March 14, 2012
Silencing of HSulf-2 expression in MCF10DCIS.com cells attenuate ductal carcinoma in situ progression to invasive ductal carcinoma in vivo
Ashwani Khurana, Hiedi McKean, Hyunseok Kim, et al.
Genes, Chromosomes & Cancer
|
October 31, 2012
The human sulfatase 2 inhibitor 2,4-disulfonylphenyl-tert-butylnitrone (OKN-007) has an antitumor effect in hepatocellular carcinoma mediated via suppression of TGFB1/SMAD2 and Hedgehog/GLI1 signaling
Xin Zheng, Xiaohong Gai, Shaoshan Han, et al.
Hepatology (Baltimore, Md.)
|
October 13, 2017
Impact of surveillance for hepatocellular carcinoma on survival in patients with compensated cirrhosis
Ju Dong Yang, Ajitha Mannalithara, Andrew J Piscitello, et al.
Page
of 40
Search research articles
Search
Showing results (101-110 of 393) with videos related to
Sort By:
Page
of 40
Hepatology Communications
|
September 30, 2022
Gaps in hepatocellular carcinoma surveillance among insured patients with hepatitis B infection without cirrhosis in the United States
Mindie H Nguyen, Lewis R Roberts, Nicole M Engel-Nitz, et al.
Cancers
|
November 13, 2021
<i>Sulfatase</i>-2 Regulates Liver Fibrosis through the TGF-β Signaling Pathway
Ikuo Nakamura, Faizal Z Asumda, Catherine D Moser, et al.
Hepatology (Baltimore, Md.)
|
January 24, 2018
Hepatic stellate cell-derived platelet-derived growth factor receptor-alpha-enriched extracellular vesicles promote liver fibrosis in mice through SHP2
Enis Kostallari, Petra Hirsova, Alena Prasnicka, et al.
Expert Opinion on Therapeutic Targets
|
January 17, 2022
Novel and emerging targets for cholangiocarcinoma progression: therapeutic implications
Lionel A Kankeu Fonkoua, Pedro Luiz Serrano Uson Junior, Kabir Mody, et al.
Hepatology (Baltimore, Md.)
|
April 9, 2013
Reply: To PMID 23055147
Roongruedee Chaiteerakij, William S Harmsen, Euijung Ryu, et al.
Scientific Reports
|
March 7, 2017
Inhibiting histone deacetylases suppresses glucose metabolism and hepatocellular carcinoma growth by restoring FBP1 expression
Jing Yang, Xin Jin, Yuqian Yan, et al.
Mayo Clinic Proceedings
|
August 8, 2015
Prognostic Value of Model for End-Stage Liver Disease Score Measurements on a Daily Basis in Critically Ill Patients With Cirrhosis
Thoetchai Peeraphatdit, Niyada Naksuk, Charat Thongprayoon, et al.
Breast Cancer Research : BCR
|
March 14, 2012
Silencing of HSulf-2 expression in MCF10DCIS.com cells attenuate ductal carcinoma in situ progression to invasive ductal carcinoma in vivo
Ashwani Khurana, Hiedi McKean, Hyunseok Kim, et al.
Genes, Chromosomes & Cancer
|
October 31, 2012
The human sulfatase 2 inhibitor 2,4-disulfonylphenyl-tert-butylnitrone (OKN-007) has an antitumor effect in hepatocellular carcinoma mediated via suppression of TGFB1/SMAD2 and Hedgehog/GLI1 signaling
Xin Zheng, Xiaohong Gai, Shaoshan Han, et al.
Hepatology (Baltimore, Md.)
|
October 13, 2017
Impact of surveillance for hepatocellular carcinoma on survival in patients with compensated cirrhosis
Ju Dong Yang, Ajitha Mannalithara, Andrew J Piscitello, et al.
Page
of 40